Profenamine
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | N04AA05 (WHO) |
| Pharmacokinetic data | |
| Protein binding | 93% |
| Biological half-life | 1 to 2 hours |
| Identifiers | |
| |
| CAS Number |
522-00-9  N |
| PubChem (CID) | 3290 |
| IUPHAR/BPS | 7181 |
| DrugBank |
DB00392  Y |
| ChemSpider |
3174 Y |
| UNII |
7WI4P02YN1 N |
| ChEBI |
CHEBI:313639 Y |
| ChEMBL |
CHEMBL1206 Y |
| ECHA InfoCard | 100.012.850 |
| Chemical and physical data | |
| Formula | C19H24N2S |
| Molar mass | 312.473 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| NY (what is this?) (verify) | |
Profenamine (INN, trade names Parsidol, Parsidan, Parkin), also known as ethopropazine (BAN), is a phenothiazine derivative used as an antiparkinsonian agent that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.
References
| Dopaminergics |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticholinergics | |||||||||||||||||||
| Others | |||||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
| Classes |
|
|---|---|
| Antidepressants (TCAs and TeCAs) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Others |
|
This article is issued from Wikipedia - version of the 10/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.